India Globalization Capital, Inc.
GPTKB entity
Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:public_company
|
| gptkbp:businessModel |
gptkb:infrastructure
development of cannabinoid-based therapies |
| gptkbp:CEO |
gptkb:Ram_Mukunda
|
| gptkbp:countryOfOperation |
gptkb:United_States
|
| gptkbp:focusArea |
gptkb:Alzheimer's_disease
gptkb:Parkinson's_disease pain management |
| gptkbp:foundedYear |
2005
|
| gptkbp:headquartersLocation |
gptkb:Bethesda,_Maryland,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
India Globalization Capital, Inc.
|
| gptkbp:industry |
pharmaceuticals
cannabis |
| gptkbp:product |
Hyalolex
IGC-AD1 |
| gptkbp:stockExchange |
gptkb:NYSE_American
|
| gptkbp:stockSymbol |
gptkb:IGC
|
| gptkbp:website |
https://www.igcinc.us/
|
| gptkbp:bfsParent |
gptkb:IGC
|
| gptkbp:bfsLayer |
7
|